| Sign In to gain access to subscriptions and/or personal tools. |
Gabapentin and Breastfeeding: A Case ReportDepartment of Pharmacy at the Womens and Childrens Health Service, Subiaco, Western Australia
Pharmacology Unit, School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia
Clinical Pharmacology & Toxicology Laboratory at PathWest Laboratory Medicine, Nedlands, Australia
Department of Neonatal Services at the Womens and Childrens Health Service, Subiaco, Western Australia The aim of this study was to describe the milk-plasma ratio and relative infant dose of gabapentin in a breastfeeding mother and to determine the well-being of her exposed infant. The mother-infant pair was studied over a 24-hour dose interval at steady state. Gabapentin concentrations were quantified by high-performance liquid chromatography. Infant exposure was calculated as concentration in milk multiplied by an estimated milk production of 0.15 L/kg/d and normalized to the weight-adjusted maternal dose. The milk-plasma ratio was 0.86; the relative infant dose was 2.34%. The absolute infant dose was approximately 3% of the childrens dose for gabapentin, and the infant plasma level of 0.4 mg/L was approximately 6% of the maternal plasma drug concentration. No adverse effects attributable to gabapentin were noted in the infant. In combination with a previously published report, these limited data support the prescription of gabapentin to a breastfeeding mother after a careful individual risk-benefit analysis.
Key Words: gabapentin human milk relative infant dose breastfeeding
Journal of Human Lactation, Vol. 22, No. 4,
426-428 (2006) |
|
||
